Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
09/2005
09/27/2005US6949545 Tissue remodeling; antiinflammatory agents; autoimmune disease
09/27/2005US6949544 Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases
09/27/2005US6949541 Substituted piperidines, medicaments containing these compounds, and methods for the production thereof
09/27/2005US6949540 Substituted pyrazoles
09/27/2005US6949539 Antiinflammatory agents; autoimmune disease; rheumatic disorders
09/27/2005US6949538 Compounds, compositions, and methods
09/27/2005US6949535 for example, 2-(6-aminopurin-9-ylmethyl)-3-(2-chlorophenyl)-6,7-dimethoxy-3H-quinazolin-4-one
09/27/2005US6949515 Amino acid side chain-modified substrates of the enzyme; obtaining locally limited inhibition; treating inflammation, psoriasis, periodontitis, allergies, arthritis, tumors or autoimmune diseases
09/27/2005US6949510 Uses of diterpenoid triepoxides as an anti-proliferative agent
09/27/2005US6949506 Relaxin-like factor and methods and uses thereof
09/27/2005CA2193337C 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients
09/27/2005CA2120942C Nitric esters of derivatives of the 2-(2,6-di-halo-phenylamino)phenyl-acetic acid and process for their preparation
09/27/2005CA2099612C Monokine mig induced by ifn-gamma
09/22/2005WO2005087789A1 Protein c and endothelial protein c receptor polymorphisms as indicators of subject outcome
09/22/2005WO2005087775A1 Tricyclic heterocyclic compound and medicinal composition containing the compound as active ingredient
09/22/2005WO2005087749A1 2-aminoquinazoline derivative
09/22/2005WO2005007169A3 Liposomes containing phosphate glycerol groups for treating acute inflammatory condition
09/22/2005WO2003099270A8 Methods of treating allergic reactions
09/22/2005US20050209462 Synthesis of benzimidate from benzoic acid
09/22/2005US20050209459 Processes for the preparation of 1,5-diryl-3-substituted-pyrazoles
09/22/2005US20050209338 Phenethanolamine derivatives for treatment of respiratory diseases
09/22/2005US20050209329 Potentiation of therapeutic effects of fatty acids
09/22/2005US20050209325 Novel interleukin-1 and tumor necrosis factor-alpha modulators, syntheses of said modulators and methods of using said modulators
09/22/2005US20050209316 Lactone formulations and method of use
09/22/2005US20050209298 treating rheumatoid arthritis by photodynamic therapy (PDT), by administering an iminochlorin aspartic acid porphyrin derivative called ATX-S10 sodium salt; determining the location of a sentinel lymph node and the presence of cancer metastasis; compounds from US patent 6063777
09/22/2005US20050209286 RXR activating molecules
09/22/2005US20050209273 Neuroprotectants, analgesics or anticonvulsants
09/22/2005US20050209253 Corticotropin releasing factor (CRF) receptor antagonists; nervous system disorders, ischemia, gastrointestinal disorders, hypertension, eating disorders, sleep disorders; e.g. 2-(1-[7-(2,6-dibromo-4-trifluoromethyl-phenyl)-2,5,6-trimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-piperidin-2-yl)-ethanol
09/22/2005US20050209252 Using an indazole compound
09/22/2005US20050209244 N{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine coated stents
09/22/2005US20050209240 such as 4-methoxybenzaldehyde O-{2-[3-(3-ethoxy-4-methoxyphenyl)-5,6-dihydro-4H-pyridazin-1-yl]-2-oxoethyl}oxime; phosphodiesterase IV inhibitors
09/22/2005US20050209230 2,4-Pyrimidinediamine compounds and their uses
09/22/2005US20050209225 Substituted indoles and their use as integrin antagonists
09/22/2005US20050209216 Inhibit the synthesis of TNF-alpha (TNF=tumor necrosis factor); use treating diseases linked to immune and inflammatory disorders or as analgesics; e.g. 7-(2-(4-(3-Trifluoromethylphenyl)piperazin-1-yl)ethyl)quinoline
09/22/2005US20050209214 1-oxa-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
09/22/2005US20050209206 Pharmaceutical formulation comprising an androstane derivative and a solubilising agent in an aqueous liquid carrier
09/22/2005US20050209201 allowing an ATP receptor antagonist ( Reactive Blue 2 ) to work on ATP receptors of cells to block them and thereby inhibit the release of inflammatory cytokines, particularly interleukin-6 (IL-6) and/or interleukin-8 (IL-8)
09/22/2005US20050209192 Autoimmune disorders; modulating protein kinase C activity
09/22/2005US20050209191 1-Aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
09/22/2005US20050209185 Synergistic mixture; administering by inhalation; tiotropium bromide; metered dose inhaler, a dry powder inhaler; asthma, chronic obstructive pulmonary disease
09/22/2005US20050209176 Compounds that interact with kinases
09/22/2005US20050209159 Effectors of dipeptidyl peptidase IV for topical use
09/22/2005US20050208619 29 human secreted proteins
09/22/2005US20050208582 Pyrazole compounds and pharmaceutical compositions comprising the compound
09/22/2005US20050208580 Novel protein and method for producing the protein
09/22/2005US20050208525 Nucleotide sequences coding preferential polypeptide for use in the treatment defects in immune and inflammatory response
09/22/2005US20050208158 nutraceutic mixture comprising plant extract of steroid saponins and bio-active zinc, bio-active selenium; treating HIV, herpes virus; antiinflammatory agent treating veins, capillaries, kidneys, bladder, and prostate gland; increasing good cholesterol concentration; strengthening immune system
09/22/2005US20050208135 Monocompartment osmotic controlled drug delivery system
09/22/2005US20050208129 Prolonged release bioadhesive therapeutic systems
09/22/2005US20050208124 Drugs containing riboflavin-type compounds
09/22/2005US20050208106 Composition containing oat straw and willow herb extract
09/22/2005US20050208061 Treatment of autoimmune diseases by oral administration of autoantigens
09/22/2005US20050208042 Inducing lack of responsiveness to an antigen in an individual having a transplanted organ, tissue, cell; administering an effective amount of a humanized antibody; one antigen binding region of nonhuman origin and a portion of an immunoglobulin heavy chain of human origin
09/22/2005US20050208035 Nutritional composition for treating an immune condition
09/22/2005US20050208016 derivatives effectively block the inflammatory effects of RANTES, and are useful for the treatment of asthma, allergic rhinitis, atopic dermatitis, atheroma/atherosclerosis, and rheumatoid arthritis, hiv
09/22/2005DE10152351B4 Feste Arzneimittelformulierung für ein Piperazinharnstoffderivat Solid pharmaceutical formulation for a Piperazinharnstoffderivat
09/22/2005CA2560098A1 2-aminoquinazoline derivative
09/22/2005CA2559555A1 Protein c and endothelial protein c receptor polymorphisms as indicators of subject outcome
09/21/2005EP1577391A1 Neutrokine alpha
09/21/2005EP1577315A1 Process for producing hop glume polyphenol
09/21/2005EP1577299A1 Alkynyl-substituted azasugar derivative and drug containing the same as the active ingredient
09/21/2005EP1576969A1 A wound care device
09/21/2005EP1576963A2 Method for treating pain by peripheral administration of a neurotoxin
09/21/2005EP1576954A1 Preferential inhibition of release of pro-inflammatory cytokines
09/21/2005EP1576169A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
09/21/2005EP1576168A2 Therapeutic polypeptides nucleic acids encoding same and methods of use
09/21/2005EP1576088A2 Dominant negative proteins and methods thereof
09/21/2005EP1575984A2 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade
09/21/2005EP1575976A2 Methods and compositions for therapeutic use of rna interference
09/21/2005EP1575964A2 N-(benzyl)aminoalkyl carboxylate, phosphinates, phosphonates and tetrazoles as edg receptor agonists
09/21/2005EP1575950A1 [1,7]naphthyridines as pde4 inhibitors
09/21/2005EP1575916A2 Phosphodiesterase activity and regulation of phosphodiesterase 1-b-mediated signaling in brain
09/21/2005EP1575594A2 Combination of reboxetine and a cyclooxygenase-2 inhibitor
09/21/2005EP1575528A2 Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
09/21/2005EP1575524A2 Proliferated cell lines and uses thereof
09/21/2005EP1575521A2 Pharmaceutical composition of 1-(3-hydroxy-4-methoxyphenyl)-4-methyl-5-ethyl-7,8-dimethoxy-5h-2,3-benzodiazepine and uses therof
09/21/2005EP1575480A2 Compositions and methods for the treatment of immune related diseases
09/21/2005EP1575414A2 Methods and devices for detection and therapy of atheromatous plaque
09/21/2005EP1575379A1 Nutritional compositions
09/21/2005EP1542728A4 Hybrid of itraconazole, cyclosporine or carvedilol with a layered silicate and a process for preparing the same
09/21/2005EP1420790B1 Use of bibn4096 in combination with other antimigraine drugs for the treatment of migraine
09/21/2005EP1401463B1 Compositions comprising thylakoids useful in the modulation of the inflammation process
09/21/2005EP1377560B1 Piperazine derivatives as tachykinin antagonists
09/21/2005EP1339694B1 Substituted 2-phenylaminoimidazoline phenyl ketone derivatives as ip antagonists
09/21/2005EP1303501B1 Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging
09/21/2005EP1140091B1 Formulations comprising imiquimod or other immune response modifiers for treating cervical dysplasia
09/21/2005EP1137640B1 Cyclic hydrazine derivatives as tnf-alpha inhibitors
09/21/2005EP1129188B1 Pge synthase and methods and means for modulating its activity
09/21/2005EP1061805B1 Regulation of endogenous gene expression in cells using zinc finger proteins
09/21/2005CN2726603Y Pain-relieving plaster for injection
09/21/2005CN1671856A Novel physiologically active substances
09/21/2005CN1671844A Antigenic neisserial peptides
09/21/2005CN1671742A Use of HMGB1 in the treatment of tissue damage and/or to promote tissue repair
09/21/2005CN1671734A CFTR modifier genes and expressed polypeptides useful in treating cystic fibrosis and methods and products for detecting and/or identifying same
09/21/2005CN1671730A Oligonucleotide-containing pharmacological compositions and their use
09/21/2005CN1671715A Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors
09/21/2005CN1671714A Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
09/21/2005CN1671711A Calcitonin gene related peptide receptor antagonists
09/21/2005CN1671701A Novel aryllimidazole derivatives, preparation and therapeutic used thereof
09/21/2005CN1671700A Substituted alkylamine derivatives and methods of use
1 ... 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 ... 1272